# Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer

> **NCT00941070** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 26 (actual)

## Conditions studied

- Recurrent Cervical Cancer
- Recurrent Vaginal Cancer
- Stage IB Cervical Cancer
- Stage II Vaginal Cancer
- Stage IIA Cervical Cancer
- Stage IIB Cervical Cancer
- Stage III Cervical Cancer
- Stage III Vaginal Cancer
- Stage IVA Cervical Cancer
- Stage IVA Vaginal Cancer
- Stage IVB Cervical Cancer
- Stage IVB Vaginal Cancer
- Therapy-related Toxicity

## Interventions

- **DRUG:** triapine
- **DRUG:** cisplatin
- **RADIATION:** external beam radiation therapy
- **PROCEDURE:** quality-of-life assessment
- **OTHER:** questionnaire administration
- **RADIATION:** fludeoxyglucose F 18
- **PROCEDURE:** positron emission tomography
- **PROCEDURE:** computed tomography

## Key facts

- **NCT ID:** NCT00941070
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-04
- **Final completion:** 2012-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941070, "Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00941070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*